Verified peer comparison
Monte Rosa Therapeutics, Inc. vs Blend Labs, Inc. Class A Common Stock Financial Comparison
Monte Rosa Therapeutics, Inc. versus Blend Labs, Inc. Class A Common Stock usin…
Direct answer
Monte Rosa Therapeutics, Inc. and Blend Labs, Inc. Class A Common Stock are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income.
Alpha Vantage
Get free Monte Rosa Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Monte Rosa Therapeutics, Inc. Revenue
- 123,672,000 USD
- Blend Labs, Inc. Class A Common Stock Revenue
- 123,585,000 USD
- Monte Rosa Therapeutics, Inc. Operating income
- -54,208,000 USD
- Blend Labs, Inc. Class A Common Stock Operating income
- -20,864,000 USD